Tiotropium Respimat® add-on therapy to inhaled corticosteroids in patients with symptomatic asthma improves clinical outcomes regardless of baseline characteristics

Autor: Casale, Thomas B., Aalbers, René, Bleecker, Eugene R., Meltzer, Eli O., Zaremba-Pechmann, Liliana, de la Hoz, Alberto, Kerstjens, Huib A.M.
Zdroj: In Respiratory Medicine October-November 2019 158:97-109
Databáze: ScienceDirect